Promising data in adult patients supports advancement into pediatric patientsData from this portion of the clinical program will inform pivotal studySAN CARLOS, Calif. (BUSINESS WIRE) #CDG Glycomine, Inc., a clinical-stage biotechnology company focused on developing new therapies for orphan diseases, announced th.
Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study with Insight into Genetic Mutations and Biomarkers for PMM2-CDG lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
This study in 139 patients with PMM2-CDG represents the largest prospective natural history dataset with more than 300 patient-years of data collected to dateData from this study lay the groundwork for future investigations into potential genotype/phenotype correlationsThe data presented at ASHG 2023 explores the im.
Glycomine Raises $68M in Series B Funding finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.